IV Bags Market
In today's healthcare landscape, intravenous (IV) therapy has gained significant traction, driven by the increasing prevalence of chronic diseases worldwide. IV therapy, known for its effectiveness in replenishing electrolyte levels and treating conditions such as diarrhoea and chronic fever, has become crucial. The World Health Organization (WHO) highlights diarrhoeal diseases as a leading cause of global mortality, particularly among children, with approximately 1.7 billion childhood cases reported annually. This epidemiological trend underscores the urgent need for efficient fluid delivery systems like IV bags. For More Industry Insight: https://www.fairfieldmarketresearch.com/report/iv-bagsmarket Expanding Scope of Parenteral Nutrition Boosts Market Potential The escalating incidence of cancer has further underscored the importance of parenteral nutrition, where IV bags play a pivotal role. Cancer-related complications, such as stomach ulcers and gastrointestinal tract disruptions, often necessitate intravenous fluid administration. The demand for IV bags is expected to rise alongside the increasing number of cancer cases, projected by the International Agency for Research on Cancer (IARC) to increase from 17 million to 27.5 million by 2040, with a corresponding rise in deaths to 16.3 million during this period. Shift Towards Sustainable IV Bag Manufacturing In response to growing environmental concerns, leading IV bag manufacturers are shifting towards sustainable practices. This includes reducing the environmental footprint of IV bag materials, such as eliminating DEHP and PVC components. Regulatory bodies like the Food and Drug Administration (FDA) have recommended alternatives that are more environmentally friendly. Companies like Baxter and B. Braun Medical Inc. have introduced